Skip to Main Content

Try STAT+ TODAY

Congress

Most Read

Politics Sarah Owermohle

What Fauci’s exit tells us about the ongoing fight against Covid

Hospitals Bob Herman

Hospitals wrangle billions in FEMA funding to offset Covid costs

First Opinion Blair L. Sadler and Alfred M. Sadler, Jr.

Organ transplantation is at a crossroads. Major reform is needed

Politics Rachel Cohrs

Pharma’s likely to sue over Medicare negotiation. Here are the arguments they might use

Politics Rachel Cohrs

Unpacking the drug pricing policies that Congress just approved

Politics Rachel Cohrs

Here’s who Democrats’ drug pricing bill will actually help

Politics Rachel Cohrs

In a massive victory for Democrats, Medicare is poised to negotiate drug prices

Politics Nicholas Florko

The politics of passing a major FDA funding bill just got complicated

All Coverage

Exclusive Rachel Cohrs

Lawmaker requests investigation into HCA over billing practices

Exclusive Rachel Cohrs

FDA funding negotiations heat up ahead of September deadline

advertisement

D.C. Diagnosis Rachel Cohrs

It’s not looking good for Covid and monkeypox funding, problems ahead for PrEP, & the not-so-historic Juul settlement

First Opinion H. Gilbert Welch

Congress should not compel Medicare to pay for liquid biopsies

Health Care Inc. Bob Herman

Private equity’s latest fixation & the ACA subsidy spigot

Politics Rachel Cohrs

Cancer patient who devoted six years to drug pricing reform isn’t done yet

Politics Rachel Cohrs

In a momentous vote for Pelosi, House sends drug pricing reforms to President Biden’s desk

Pharmalot Ed Silverman

Wyden wants details on Amgen’s U.S. taxes as part of expanding probe into pharma practices

D.C. Diagnosis Elissa Welle

Democrats’ TGIF moment, pathologists defend their turf, & Biogen’s back at the FDA’s doorstep

Matt's Take Matthew Herper

The Senate’s drug pricing bill is an inevitable solution. It will still have plenty of unintended consequences

Health Care Inc. Bob Herman

A lobbying frenzy over surprise billing, employer dialysis questions, and a big broker throwdown

Politics Rachel Cohrs

Democrats dramatically narrow their ambitions for lowering insulin costs

Politics Rachel Cohrs

Democrats will have to limit their drug pricing reforms to Medicare to comply with Senate rules

Politics Rachel Cohrs

The glaring health equity gap in Democrats’ drug pricing plan

The Readout LOUD Damian Garde, Allison DeAngelis and Adam Feuerstein

Listen: The last-minute push for drug pricing reform, Alnylam’s success, and Sarepta’s gamble

D.C. Diagnosis Edward Chen

A chaotic sprint to lower insulin prices and AIDS activists go after Biden on monkeypox

First Opinion David Blumenthal

Keeping climate provisions in the budget reconciliation act is a key step toward protecting Americans’ health

D.C. Diagnosis Rachel Cohrs

The view on drug pricing from Wall Street, a pharma-friendly Dem holds firm, and what’s next for a big telehealth bill

Pharmalot Ed Silverman

Wyden says Merck and Abbott aren’t cooperating with probe into pharma tax practices

Politics Nicholas Florko

Senators demand answers about federal prisons’ scant use of Covid therapeutics

Politics Rachel Cohrs

‘What can we do?’: Pharma lobbyists face their biggest test in a decade, as Democrats barrel toward a vote on drug pricing

First Opinion Craig Garthwaite

Drug price controls are a dance with the devil: short-term savings will be overwhelmed by loss of innovation

Politics Nicholas Florko

Powerful Senate Democrat outlines ‘plenty’ more drug pricing reforms to follow Medicare negotiation

Health Care Rachel Cohrs

Virtual Event: Democrats’ Last Chance for Drug Pricing Reform?

D.C. Diagnosis Nicholas Florko

PhRMA and BIO descend on D.C. & unpacking the Senate’s FDA funding drama